Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results;Enfermedad pulmonar obstructiva crónica en pacientes ingresados por insuficiencia cardiaca. Resultados del Grupo para el Estudio y Significado de la Anemia en la Insuficiencia Cardiaca (GESAIC)

Medicina Clinica

Volumn 134, Issue 10, 2010, Pages 427-432

  Recio Iglesias, Jesús ^a   Grau Amorós, Jordi ^b   Formiga, Francesc ^c   Camafort Babkowski, Miquel ^d   Trullàs Vila, Joan Carles ^e   Rodríguez, Avelino ^f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Hospital Municipal de Badalona   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Hospital Comarcal Mora d'Ebre   (Spain)

^e Hospital Sant Jaume de Olot   (Spain)

^f UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

Beta blockers; COPD; Heart failure; Prevalence

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SPIROMETRY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; FEMALE; HEART DISEASES; HEART FAILURE; HUMANS; HYPERTENSION; INPATIENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; OVERWEIGHT; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 77950595160     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.09.046     Document Type: Article

References (27)

1. J.B. Braunstein, G.F. Anverso, G. Gerstenblith, W. Weller, M. Niefeld, and R. Herbert Noncardiac comorbidity increases presentable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233 (Pubitemid 37188347)
2. J. Forteza-Rey Comorbilidad e insuficiencia cardiaca Rev Clin Esp 201 2001 16 21
3. J.J. Soler-Cataluña, M.A. Martínez-García, P. Román Sánchez, E. Salcedo, M. Navarro, and R. Ochando Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax 60 2005 925 931 (Pubitemid 41598207)
4. I. Antonelli, L. Fuso, M. De Rosa, F. Forastiere, E. Rapiti, B. Nardecchia, and R. Pistelli Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease Eur Respir J 10 1997 2794 2800 (Pubitemid 28052790)
5. L. Huiart, P. Ernst, and S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646 (Pubitemid 41507622)
6. S. Sidney, M. Sorel, C.P. Quesenberry Jr, and C. DeLuise COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program Chest 128 2005 2068 2075 (Pubitemid 41507542)
7. M. Egred, S. Shaw, P. Waitt, and E. Rodríguez Under-use of beta-blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease Q J Med 98 2005 493 497 (Pubitemid 41418672)
8. F.H. Rutten, M.J. Cramer, D.E. Grobbee, A.P. Sachs, J.H. Kirkels, J.W. Lammers, and A.W. Hoes Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 261 2005 887 894
9. J.G.F. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, and J.C. Aguilar The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe Eur Heart J 24 2003 442 463 (Pubitemid 36286188)
10. J. Grau-Amorós, F. Formiga, R. Jordana-Comajuncosa, A. Urrutia, O. Aramburu Bodas, L.M. Ceresuela en nombre del estudio GESAIC Prevalencia de la anemia en la insuficiencia cardiaca. Resultados el estudio GESAIC Rev Clin Esp 208 2008 211 215 (Pubitemid 351743990)
11. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: The Framingham study N Engl J Med 285 1971 1441 1446
12. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2006). [Consultado 19/9/2008]. Disponible en: http://www.goldcopd.org
13. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2005;112:e154-5
14. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26:1115-1140.
15. E.P. Havranek, F.A. Masoudi, K.A. Westfall, P. Wolfe, D.L. Orden, and H.M. Krumholz Spectrum of heart failure in older patient: Results from the National Heart Failure Project Am Heart J 143 2002 412 417 (Pubitemid 34187650)
16. M. Padeletti, S. Jelic, and T.H. LeJemtel Coexistent chronic obstructive pulmonary disease and heart failure in the elderly Int J Cardiol 125 2008 209 215
17. D. Rusinaru, I. Saaidi, S. Godard, H. Mahjoub, C. Battle, and C. Tribouilloy Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure Am J Cardiol 118 2008 605 610 (Pubitemid 351162971)
18. Grupo de trabajo de insuficiencia cardiaca de la Sociedad Española de Medicina Interna (SEMI) La insuficiencia cardiaca en los servicios de medicina interna (estudio SEMI-IC). Med Clin (Barc). 2002;118:605-10
19. W.Q. Gan, S.F. Man, D.S. Postma, P. Camp, and D.D. Sin Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: A systematic review and meta-analysis Respir Res 7 2006 52
20. A. Johannnessen, E. Omenaas, P. Bakke, and A. Gulvsvik Incidence of GOLD defined chronic obstructive pulmonary disease in a general adult population Int J Tuberc Lung Dis 9 2005 926 932 (Pubitemid 41139654)
21. D.D. Sin, and S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
22. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane database Syst Rev. Reviews 2005 Issue 4 John Wiley & Sons, Ltd Chichester, UK. DOI: 10.1002/14651858. CD003566.pub2.
23. A. Macchia, S. Monte, M. Romero, A. D'Ettore, and G. Tognoni The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure Eur J Heart Fail 9 2007 942 948 (Pubitemid 47332320)
24. M.S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, and V.P. Harjola et al. On behalf of the EuroHeart SurveyInvestigators. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population Eur Heart J 27 2006 2725 2736
25. Manuel Anguita Sánchez y Grupo Investigador del Registro B.A.D.A.P.I.C. Características clínicas, tratamiento y mortalidad a corto plazo de pacientes con insuficiencia cardiaca controlados en consultas específicas de insuficiencia cardiaca, Resultados del registro BADAPIC. Rev Esp Cardiol. 2004;57:1159-69
26. N. Galofré, L. San Vicente, J.A. González, F. Planas, J. Vilá, and J. Grau Morbimortalidad de los pacientes ingresados por insuficiencia cardiaca. Factores predictores de reingreso Med Clin 124 2005 285 290 (Pubitemid 40478020)
27. A. Urrutia, J. Lupón, S. Altimir, B. González, J. Herreros, and C. Díez et al. Uso de bloqueadores beta en pacientes ancianos con insuficiencia cardiaca Med Clin 126 2006 206 210